IN BRIEF: NetScientific Says Blanver Joins Covid Vaccine Consortium

23rd Feb 2021 16:55

NetScientific PLC - life sciences and technology investment and commercialisation company - Says Blanver Farmoquímica e Farmacêutica SA joins the Covid-19 vaccine commercialisation consortium run by NetScientific's portfolio company PDS Biotechnology Corp and Farmacore Biotechnology. Notes Sao Paulo-based Blanver will manufacture, promote, distribute, and commercialize the Versamune-based Covid vaccine in Latin America. NetScientific has a 5.8% stake in PDS

Current stock price: 65.65 pence

Year-to-date change: up 41%

By Ife Taiwo; [email protected]

Copyright 2021 Alliance News Limited. All Rights Reserved.

---

Related Shares:

Netscientific